John Hardy (geneticist)
| John Hardy | |
|---|---|
| Born |
John Anthony Hardy 9 November 1954 |
| Institutions | |
| Alma mater |
|
| Thesis | The release of amino acids and phenylethylamine from mammalian synaptosomes (1981) |
| Notable awards |
|
|
Website www | |
John Anthony Hardy FRS[1] (born 9 November 1954) is a human geneticist and molecular biologist at the Reta Lila Weston Institute of Neurological Studies at University College London with research interests in neurological diseases.[3][4][5][6]
Education
Hardy received his Bachelor of Science degree from the University of Leeds in 1976[7] and his PhD from Imperial College London in 1981[7] for research on dopamine and amino acid neuropharmacology.
Career and research
Following his PhD, Hardy did postdoctoral research at the MRC Neuropathogenesis Unit in Newcastle upon Tyne, England and then further postdoctoral work at the Swedish Brain Bank in Umeå, Sweden where he started to work on Alzheimer's disease.[7]
He became Assistant Professor of Biochemistry at St. Mary's Hospital, Imperial College London in 1985 and initiated genetic studies of Alzheimer's disease there.[8] He became Associate Professor in 1989 and then took the Pfeiffer Endowed Chair of Alzheimer's Research at the University of South Florida, in Tampa in 1992. In 1996 he moved to Mayo Clinic in Jacksonville, Florida, as Consultant and Professor of Neuroscience.
He became Chair of Neuroscience in 2000 and moved to National Institute on Aging, Bethesda, Maryland, as Chief of the Laboratory of Neurogenetics in 2001. In 2007 he took up the Chair of Molecular Biology of Neurological Disease at the Reta Lila Weston Institute of Neurological Studies, University College London.
On November 29, 2015, he was awarded the Breakthrough Prize.
Awards and honours
Among other awards and honours, Hardy has won the Breakthrough Prize in Life Sciences for dissecting the causes of Alzheimer’s disease, Parkinson's disease and frontotemporal dementia; the MetLife prize for research into Alzheimer's disease, and the Potamkin Prize for his work in describing the first genetic mutations in the amyloid gene in Alzheimer's disease, in 1991. He was elected a Fellow of the Royal Society (FRS) in 2009.[1]
- 2015 - Breakthrough Prize in Life Sciences [9]
- 2015 - Member of the European Molecular Biology Organization (EMBO)[10][11]
- 2014 - the The Michael J. Fox Foundation award for Parkinson research [12]
- 2014 - Thudichum Medal from the Biochemical Society
- 2014 - Dan David Prize[13]
- 2011 - Elected Fellow of the Institute of Biology
- 2010 - Honorary Doctor of Science, Newcastle University
- 2009 - Elected Fellow of the Royal Society[1]
- 2008 - Honorary MD, Umeå University, Sweden,
- 2008 - Elected a Fellow of the Academy of Medical Sciences (FMedSci)[2]
- 2008 - Anne Marie Oprecht International Prize for Research in Parkinson’s Disease
- 2002 - Kaul Prize for Research into Alzheimer’s disease
- 1995 - MetLife Prize for Research into Alzheimer’s disease
- 1995 - Allied Signal Prize for Research into Aging
- 1993 - Potamkin Prize from the American Academy of Neurology, for Alzheimer's Research
- 1992 - IPSEN Prize for Research into Alzheimer's Disease
- 1991 - Peter Debje Prize, University of Limburg, Belgium, For Alzheimer's Research
References
- 1 2 3 4 "Professor John Hardy FMedSci FRS". London: Royal Society. Archived from the original on 2015-11-17.
- 1 2 "Professor John Hardy FRS FMedSci".
- ↑ HARDY, Prof. John. Who's Who 2015 (online Oxford University Press ed.). A & C Black, an imprint of Bloomsbury Publishing plc. (subscription required)
- ↑ Hutton, Mike; Heutink, Peter; Lendon, Corinne L.; Rizzu, Patrizia; Baker, Matt; Froelich, Susanne; Houlden, Henry; Pickering-Brown, Stuart; Chakraverty, Sumi; Isaacs, Adrian; Grover, Andrew; Hackett, Jennifer; Adamson, Jennifer; Lincoln, Sarah; Dickson, Dennis; Davies, Peter; Petersen, Ronald C.; Stevens, Martijn; de Graaff, Esther; Wauters, Erwin; van Baren, Jeltje; Hillebrand, Marcel; Joosse, Marijke; Kwon, Jennifer M.; Nowotny, Petra; Che, Lien Kuei; Norton, Joanne; Morris, John C.; Reed, Lee A.; Trojanowski, John; Basun, Hans; Lannfelt, Lars; Neystat, Michael; Fahn, Stanley; Dark, Francis; Tannenberg, Tony; Dodd, Peter R.; Hayward, Nick; Kwok, John B. J.; Schofield, Peter R.; Andreadis, Athena; Snowden, Julie; Craufurd, David; Neary, David; Owen, Frank; Oostra, Ben A.; Hardy, John; Goate, Alison; van Swieten, John; Mann, David; Lynch, Timothy (1998). "Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17". Nature 393 (6686): 702–705. doi:10.1038/31508. ISSN 0028-0836. PMID 9641683.
- ↑ Goate, Alison; Chartier-Harlin, Marie-Christine; Mullan, Mike; Brown, Jeremy; Crawford, Fiona; Fidani, Liana; Giuffra, Luis; Haynes, Andrew; Irving, Nick; James, Louise; Mant, Rebecca; Newton, Phillippa; Rooke, Karen; Roques, Penelope; Talbot, Chris; Pericak-Vance, Margaret; Roses, Alien; Williamson, Robert; Rossor, Martin; Owen, Mike; Hardy, John (1991). "Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease". Nature 349 (6311): 704–706. doi:10.1038/349704a0. ISSN 0028-0836.
- ↑ Hardy, J. (2002). "The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to Therapeutics". Science 297 (5580): 353–356. doi:10.1126/science.1072994. ISSN 0036-8075.
- 1 2 3 Neuroscience NIH Archived December 10, 2015, at the Wayback Machine.
- ↑ HIH.gov Archived November 5, 2011, at the Wayback Machine.
- ↑ https://breakthroughprize.org/ Breakthrough Prize 2016
- ↑ "The EMBO Pocket Directory" (PDF). European Molecular Biology Organization. Archived from the original on 2015-03-16.
- ↑ "EMBO announces new members for 2015". Heidelberg: European Molecular Biology Organization.
- ↑ Pritzker, MJ Fox Award for Parkinson Research
- ↑ "Dan David Prize: LAUREATES 2014: Combatting Memory Loss, JOHN A. HARDY".
|